← Insider buys
CRNX

Crinetics Pharmaceuticals, Inc. · Healthcare

Director Stephanie Okey sold $246K of Crinetics Pharmaceuticals, Inc.

Sold$246,143
$35.67Price
6,900Shares
−52%Stake

What CRNX did after the filing

Filed Jun 18Copier in Jun 22
The stock from Mon, Jun 22 open, $35.91
+133.5%
S&P 500, same days
+3.2%

Measured over 30 trading days, to the Aug 4 close.

Traded Wed, Jun 17. Filed Thu, Jun 18, 5:23 PM ET, after the close. Returns use the Jun 22 open and the Aug 4 close. Not investment advice.